Data as of Jul 31
| -1.38 / -2.51%|
The 19 analysts offering 12-month price forecasts for Teva Pharmaceutical Industries Ltd have a median target of 57.00, with a high estimate of 70.00 and a low estimate of 48.00. The median estimate represents a +6.54% increase from the last price of 53.50.
The current consensus among 25 polled investment analysts is to Hold stock in Teva Pharmaceutical Industries Ltd. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.